Join our daily newsletter At The Bell to receive exclusive market insights
- Audeara (AUA) is set to supply the only headphones stocked by Amplifon clinics at more than 300 sites across Australia
- The move is slated to strengthen the pair’s commercial relationship
- Audeara’s managing director James Fielding says the company shares Amplifon’s vision to help Australians rediscover the joy of hearing
- Shares have closed flat at 12 cents each on October 11
Audeara (AUA) is looking to strengthen its commercial relationship with Amplifon Australia by supplying the only headphones stocked by Amplifon clinics across more than 300 sites nationwide.
AUA says its algorithm allows customers to personalise sound for their unique hearing profile, offering superior sound experience and quality while promoting the importance of hearing health.
The company’s commercial partner, Amplifon, was founded 70 years ago and is regarded by Audeara as a global leader in the hearing care market.
AUA’s managing director James Fielding said following a successful trial, Amplifon would be able to purchase the company’s headphones in volume and hold stock in its clinics for immediate sale.
“Having the product readily available for clients is a great value add to streamline the provision of high quality services through the Amplifon network,” Dr Fielding said.
“Audeara shares Amplifon’s vision to help Australians rediscover the joy of hearing and we’re proud to be part of that journey.”
Back in May, AUA raised $7 million through an initial public offering to strengthen its position in the Australian audiology clinics and said it was continuing its strategy.
Amplifon Australia’s general manager Liliana Comitini said the company prided itself on providing the highest quality service and hearing solutions to meet client needs.
“Having Audeara headphones readily available to our clients helps us ensure that clients can leave with a solution to meet their needs,” Ms Comitini said.
“Their quality, versatility and of course the sound personalisation, make them a valuable part of the Amplifon offering.”
Shares closed flat at 12 cents each on October 11.
